{{$ActivityName}}
(Kindly fill in the relevant information or tick, as appropriate.)
A. Clinical examination
B. IgE levels
C. Blood tests
D. Serum skin tests
A. < 15 years
B. 15-30 years
C. 30-50 years
D. 50 years and above
A. 4-6 weeks
B. 6-12 weeks
C. 12-18 weeks
D. More than 18 weeks
A. Double dose of anti-histamines
B. Anti-histamines plus cyclosporine
C. Anti-histamines plus omalizumab
D. Omalizumab plus cyclosporine
A. Non- sedative property
B. Efficacy similar to levo-cetirizine
C. No drug- drug interaction
D. All of the above
A. Very much improved
B. Improved
C. Unchanged
D. Minimally Worse
E. Worse
A. Very well tolerated
B. Well tolerated
C. Not well tolerated
D. Serious side effects are reported frequently